New Guidelines Clarify Use of Systemic Therapy in Advanced HCC New Guidelines Clarify Use of Systemic Therapy in Advanced HCC
The American Gastroenterological Association published recommendations to help guide the management of hepatocellular carcinoma in the first- and second-line settings.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 24, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Atrial Fib, Elevated Lipids Raise Stroke Risk in Cancer Patients Atrial Fib, Elevated Lipids Raise Stroke Risk in Cancer Patients
New-onset or pre-existing AF predicted acute ischemic stroke or TIA in patients with cancer -- as did renal disease, dyslipidemia, and active cancer therapy -- in a case-control study.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 24, 2022 Category: Cancer & Oncology Tags: Cardiology News Source Type: news

My Patient Proved Me Wrong My Patient Proved Me Wrong
These patients ' cases appeared dire. Did their families transform their outcomes?Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 23, 2022 Category: Cancer & Oncology Tags: Family Medicine/Primary Care News Source Type: news

Genetic Score Predicts Lifetime Risk of Prostate Cancer Death Genetic Score Predicts Lifetime Risk of Prostate Cancer Death
A novel screening tool was able to accurately identify people with high vs low lifetime risks of developing metastatic prostate cancer or dying from the disease across diverse groups of men.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 23, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Patients With Colorectal Cancer: OK to Eat Meat? Patients With Colorectal Cancer: OK to Eat Meat?
A study of patients with colorectal cancer found no increased risk of recurrence or death with post-diagnosis intake of red and processed meat.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 23, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Poor Trial Representation Tied to Worse Breast Cancer Survival Poor Trial Representation Tied to Worse Breast Cancer Survival
More than half of patients with early breast cancer are not well represented in clinical trials yet are receiving therapies based on results of these trials.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 23, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Data Review: Spironolactone Not Linked to Increased Cancer Risk Data Review: Spironolactone Not Linked to Increased Cancer Risk
The drug ' s antiandrogenic properties have driven its off-label use as a treatment for acne, hidradenitis, androgenetic alopecia, and hirsutism, and it is also used in gender-affirming care.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 22, 2022 Category: Cancer & Oncology Tags: Dermatology News Source Type: news

Gene Therapy: A'One and Done' Hemophilia B Treatment? Gene Therapy: A'One and Done' Hemophilia B Treatment?
Nearly all patients treated with a one-time gene therapy shot for hemophilia B were able to discontinue full-dose bleeding prophylaxis, says a study. Annual bleed rates fell by 64% after the lead-in period.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 22, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Twitter Storm Over'Reprehensible Behavior' at Conference Podium Twitter Storm Over'Reprehensible Behavior' at Conference Podium
A Twitter post calling out an exchange between a presenter and an attendee asking questions at the recent GUCS conference created a bit of a buzz.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 22, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Geography Hampers Access to Lung Cancer Screening Geography Hampers Access to Lung Cancer Screening
Many individuals who are eligible for lung cancer screening have limited or no access to a facility that conducts such screening, not only in rural areas, but also in urban areas.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 22, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

PARP Inhibitors: Improving Outcomes in Metastatic Prostate Cancer PARP Inhibitors: Improving Outcomes in Metastatic Prostate Cancer
Two new trials exploring this approach ― olaparib in the PROpel trial and niraparib in the MAGNITUDE trial –― had slightly different results.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 22, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Diversity Among Oncologists Not Reflective of US Population Diversity Among Oncologists Not Reflective of US Population
While the representation of women in radiation oncology and medical oncology academic faculties has increased over time, racial and ethnic minorities are still vastly underrepresented in these fields.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 20, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

FDA Hints at Deadlines to Meet Accelerated Approval Requirements FDA Hints at Deadlines to Meet Accelerated Approval Requirements
Three physicians with the FDA are suggesting that it might be time to give drug companies a deadline to meet accelerated approval requirements, as is done in other countries.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 20, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Adding Darolutamide: New SOC for Metastatic Prostate Cancer Adding Darolutamide: New SOC for Metastatic Prostate Cancer
Darolutamide added onto ADT and docetaxel could be a new standard of care for men with metastatic hormone-sensitive prostate cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 19, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Oncologists Report Lower Burnout Compared to Other Specialities Oncologists Report Lower Burnout Compared to Other Specialities
A new Medscape survey shows that oncologists have fared better than other specialties when it comes to burnout and appear to have maintained higher levels of happiness.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 18, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news